Evaluation of Dimebon in cellular model of Huntington's disease

BACKGROUND: Dimebon is an antihistamine compound with a long history of clinical use in Russia. Recently, Dimebon has been proposed to be useful for treating neurodegenerative disorders. It has demonstrated efficacy in phase II Alzheimer's disease (AD) and Huntington's disease (HD) clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jun, Li, Qin, Bezprozvanny, Ilya
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2577671/
https://www.ncbi.nlm.nih.gov/pubmed/18939977
http://dx.doi.org/10.1186/1750-1326-3-15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2577671/
https://www.ncbi.nlm.nih.gov/pubmed/18939977
http://dx.doi.org/10.1186/1750-1326-3-15

Ejemplares similares